Search - tctmd.com

Displaying 41 - 60 of 85

Sort: Relevancy | Date

News Daily News

Cannabis Use Again Tied to Increased CVD Risk in Young People

L.A. McKeown

March 19, 2025

News Daily News

Newer Weight-Loss Drugs Not Cost-effective at Current Prices

Michael O'Riordan

March 18, 2025

Presentation CTO 2025

Assessing the Burden of Obesity in Chronic Total Occlusion Intervention: In-Hospital Mortality and Readmission Outcomes Post-PCI

Presenter: Vishnu Shenoy

February 28, 2025

News Daily News

GLP-1 Drugs in Diabetes Don’t Raise Suicidality Risk, New Data Confirm

Caitlin E. Cox

February 26, 2025

News Conference News THT 2025

Tirzepatide Helps in HFpEF Across Spectrum of Obesity Severity

Todd Neale

February 12, 2025

Presentation THT 2025

Weight Loss Improves Outcome in HFpEF: Summarizing the Clinical Evidence

Presenter: Marco Metra

February 12, 2025

Presentation THT 2025

Is There a Role for Obesity in the Progression of Heart Failure With a Reduced Ejection Fraction?

Presenter: Javed Butler

February 12, 2025

Presentation THT 2025

Inflammation as a Target in Acute HF

Presenter: Gad Cotter

February 12, 2025

Presentation THT 2025

Inflammation and HFpEF: Rationale for HERMES

Presenter: Mark Petrie

February 12, 2025

Presentation THT 2025

How Does Weight Loss Improve Hemodynamics in Patients With HFpEF

Presenter: Barry Borlaug

February 12, 2025

Presentation THT 2025

From Obesity to Inflammation: Common Pathways and New Opportunities in HF

Presenter: Milton Packer

February 12, 2025

Presentation THT Abstracts 2025

Impact of Obesity on Clinical Outcomes of Cardiogenic Shock Patients Treated With Advanced Mechanical Circulatory Support

Presenter: Abduljabar Adi

February 11, 2025

Presentation THT 2025

Impact of Obesity Severity on the Effects of Tirzepatide in HFpEF: The SUMMIT Trial

Presenter: Barry Borlaug

February 11, 2025

Presentation THT 2025

Obesity: Assessing the Weight of the Evidence

Presenter: Milton Packer

February 11, 2025

Presentation THT 2025

Impact of Obesity on Clinical Outcomes of Cardiogenic Shock Patients Treated With Advanced Mechanical Circulatory Support

Presenter: Abduljabar Adi

February 11, 2025

Presentation THT 2025

Obesity, Insulin Resistance, and Cardiovascular Disease: The Link between Metabolism and Inflammation

Presenter: Carolyn Lam

February 11, 2025

Presentation THT 2025

Inflammation and Heart Failure: Pathophysiology and Clinical Implications

Presenter: Marat Fudim

February 11, 2025

Presentation THT 2025

Emerging Therapies Targeting Inflammation and Metabolic Dysfunction in Heart Failure

Presenter: Mark Petrie

February 11, 2025

Presentation THT 2025

Case Discussion and Panel Q&A: Multidisciplinary Approaches to Managing Inflammation and Obesity in CVD

Presenter: Josephine Harrington

February 11, 2025

Presentation THT 2025

Obese HFpEF Patients Exhibit Distinct Augmentation Patterns of VO2 Components During Exercise

Presenter: Takenori Ikoma

February 11, 2025

Advertisement

Cannabis Use Again Tied to Increased CVD Risk in Young People

Newer Weight-Loss Drugs Not Cost-effective at Current Prices

Assessing the Burden of Obesity in Chronic Total Occlusion Intervention: In-Hospital Mortality and Readmission Outcomes Post-PCI

GLP-1 Drugs in Diabetes Don’t Raise Suicidality Risk, New Data Confirm

Tirzepatide Helps in HFpEF Across Spectrum of Obesity Severity

Weight Loss Improves Outcome in HFpEF: Summarizing the Clinical Evidence

Is There a Role for Obesity in the Progression of Heart Failure With a Reduced Ejection Fraction?

Inflammation as a Target in Acute HF

Inflammation and HFpEF: Rationale for HERMES

How Does Weight Loss Improve Hemodynamics in Patients With HFpEF

From Obesity to Inflammation: Common Pathways and New Opportunities in HF

Impact of Obesity on Clinical Outcomes of Cardiogenic Shock Patients Treated With Advanced Mechanical Circulatory Support

Impact of Obesity Severity on the Effects of Tirzepatide in HFpEF: The SUMMIT Trial

Obesity: Assessing the Weight of the Evidence

Impact of Obesity on Clinical Outcomes of Cardiogenic Shock Patients Treated With Advanced Mechanical Circulatory Support

Obesity, Insulin Resistance, and Cardiovascular Disease: The Link between Metabolism and Inflammation

Inflammation and Heart Failure: Pathophysiology and Clinical Implications

Emerging Therapies Targeting Inflammation and Metabolic Dysfunction in Heart Failure

Case Discussion and Panel Q&A: Multidisciplinary Approaches to Managing Inflammation and Obesity in CVD

Obese HFpEF Patients Exhibit Distinct Augmentation Patterns of VO2 Components During Exercise

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content